Um... have you looked at these results?
They consist of an angiogram of one person showing... what? I'm not sure. I'm not a radiologist. No analysis published.
And a "trial" with ONE SUBJECT. Yes only 1 person was in their "trial". Here it is:
https://www.cholrem...._Trial_2021.pdf
Giving something to one person and seeing any results at all is not a trial. There's very little that can be said from it, and certainly not enough to make a claim that it works.
As I said in an earlier post this is a really poorly reported trial. However we have a good amount of data from the Niemans Pick Disease kids whose whole issue is the build up of cholesterol and it is doing exactly what animal studies have shown clearing cholesterol in humans in vitro
https://ncats.nih.go...in-niemann-pick
This has been so successful that the they have expanded access to include home usage.
https://www.ncbi.nlm...les/PMC6805667/
Which brings the up the elephant in the room . Why no human trials? Here we have a cheap (non patentable) substance, classified by the FDA as non toxic drug that has far less side effect than commonly suppled cholesterol drugs that strangely resist a human trial. It is also increasingly used in more and more formularies both oral and injectable to the point I could take up vast amount of space listing them all on this post.
My thoughts on this as posted before is simply that the medical industry by exploring this would lose a ton of good paying customers on the medical and pharma side of the equation to the point of losing billion.
I have personally injected thus far 2200 grams with very little issue and obvious changes...so I have been trying to wrap my head around this very issue. And so has the mother of the twins who started the NPD study to the point of a 100 million lawsuit.
https://www.rgj.com/...ers/4390267002/
Let's look further at the many useful studies and results.
https://www.ncbi.nlm...les/PMC6995511/
So then back to the original query about the lack of human trials . Who pays for them?
The sponsor of the study (such as the government, drug makers or technology companies) typically pays for all costs involved with a clinical research study. This includes supplying the new treatment, as well as any special testing, possible extra physician visits, and research costs involved in the clinical studies. Each study sponsor identifies top nationwide physicians to partner with to administer the actual study with qualified patients. The FDA requires that participants in clinical studies receive all study-related doctor visits, diagnostic testing and study treatments free of charge. This is in return for being a willing participant in the clinical trial.
So we have 2 payers for research that has a financial interest and as I have observed government entities that are more and more influenced by lobbyist. I mean somehow Oxycotin was approved and was an absolute disaster...but this cheap common substance with little to no side effect can't get a human trial.
Somehow I smell a rat.
https://www.theledge...es/26426669007/
This lady had to fight to get her kids treated for something that is already being injected all over the place.... it really doesn't make sense until you look at profits. And that is why I am here and a few other bold people are here as well.